Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?

Lancet. 1973 May 19;1(7812):1085-8. doi: 10.1016/s0140-6736(73)90396-6.
No abstract available

MeSH terms

  • Animals
  • Antibody Specificity
  • Antilymphocyte Serum*
  • Carcinoma, Transitional Cell / immunology*
  • Carcinoma, Transitional Cell / radiotherapy
  • Cells, Cultured
  • Cytotoxicity Tests, Immunologic
  • Humans
  • Immunity, Cellular
  • Rabbits / immunology
  • T-Lymphocytes / immunology*
  • Time Factors
  • Urinary Bladder Neoplasms / immunology*
  • Urinary Bladder Neoplasms / radiotherapy

Substances

  • Antilymphocyte Serum